About ILS Genomics
ILS Genomics is a company based in Durham (United States) founded in 2012 was acquired by LabCorp in July 2015. ILS Genomics operates in a competitive market with competitors including ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ILS Genomics
Detailed funding history for ILS Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ILS Genomics
ILS Genomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for ILS Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ILS Genomics
Investment portfolio details for ILS Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ILS Genomics
Detailed financials for ILS Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ils Genomics Comparisons
Peer comparison for ILS Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ILS Genomics
ILS Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Natera, Variantyx, ImaginAb and RareCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Genetic sequencing is provided for late-stage cancer patients.
|
Detailed competitors of ILS Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ils Genomics
Complete news archive for ILS Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ILS Genomics
ILS Genomics was founded in 2012.
ILS Genomics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
ILS Genomics was founded in 2012 in Durham, United States, within the biotechnology sector focused on toxicology. A range of services is offered, including study design, execution, sample analysis, and interpretation in investigative toxicology, histology, pathology, and genetic toxicology. Support for evaluating alternative toxicological methods is provided, alongside environmental services. Data acquisition, management, and analysis are facilitated through the Information Science Program.
ILS Genomics's top competitors include Natera, ImaginAb and Lantern Pharma.
ILS Genomics has 1 investor. Key investors include LabCorp.